Is Thymosin Alpha-1 Legal in Michigan?

HealthRX.com

Not FDA-approved in the US, and no Michigan-specific rule found

1.6 mgDose of Zadaxin, the finished injection sold outside the USSource: fda.gov

Print or save as PDF

Key numbers

  • 4 yes and 17 noFDA advisory committee vote on thymosin alpha-1 for the pharmacy bulks listSource: fda.gov, as cited Nov 8, 2026
  • over 35 countriesNumber of countries where thymosin alpha-1 is approved, per an older review tied to its developerSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 8, 2026
  • 1.6 mgDose of Zadaxin, the finished injection sold outside the USSource: fda.gov, as cited Nov 8, 2026
  • FDA approval / None in the US; orphan drug designations are not approvals [1]
  • Approved elsewhere / Italy, India and Hong Kong; Zadaxin 1.6 mg injection [1]
  • State-licensed pharmacies / In none of FDA's three categories; the category 1 policy does not apply [3]
  • Outsourcing facilities / Category 3, 'nominated without adequate support' [4]
  • FDA advisory vote / 4 yes, 17 no on the free base and the acetate, December 2024 [5]
  • Withdrawn nomination / FDA's concerns about immunogenicity and impurities remain posted [6]
  • Sport / Not named on WADA's 2026 Prohibited List [7]

Is thymosin alpha-1 approved as a drug?

Not in the United States. There is no US marketing application for thymosin alpha-1, and its four US orphan drug designations come from a separate process that is not an approval [1].

It is approved as a medicine in some other countries. FDA's December 2024 review lists Italy, where Zadaxin is authorized as an adjuvant to influenza vaccination in immunocompromised people; India, for chronic hepatitis B in adults 18 or older with compensated liver disease and virus replication; and Hong Kong [1]. The European Medicines Agency holds only an orphan designation for hepatocellular carcinoma, not a marketing approval [1]. Two older reviews by authors tied to the Zadaxin developer put the count at 'over 35 countries' (2009) and 'more than 30 countries' (2007) [8][9].

Zadaxin is the finished 1.6 mg injection sold outside the US and is not interchangeable with bulk thymosin alpha-1 powder [1].

What people on Reddit report

Comments from an r/cfs thread about thymosin alpha-1 use. Some discuss its status abroad and in the US, and where people get it.

tansy20bartlett · cfs

Thymosin alpha 1 is a prescription drug in many counties (one brand name is Zadaxin), there are many publications on its use and side effects and it has an excellent safety profile.

Commenter says the drug is prescription abroad, but that FDA has blocked its use in the US.

Read the source discussion

tansy20bartlett · cfs

However, it's use has been blocked by the FDA, so for many the only way to obtain it is via the grey "research only" market, where LPS testing is very rarely done.

Commenter says many people in the US get it from a research-only market where contamination testing is rare.

Read the source discussion

brainfogforgotpw · cfs

TA1, aka thymosin alpha 1, does not yet have FDA approval.

Commenter points out that the drug does not have FDA approval and urges caution.

Read the source discussion

Can a compounding pharmacy make thymosin alpha-1?

FDA's list for state-licensed pharmacies, updated May 14, 2026, has three categories. Thymosin alpha-1 is in none of them, so the category 1 policy — generally no action against compounders that meet its conditions — does not apply to it [3].

FDA proposed that the peptide not be added to the pharmacy bulks list. On December 4, 2024 its Pharmacy Compounding Advisory Committee voted 4 yes and 17 no, with no abstentions, on both the free base and the acetate; members who voted no cited no compelling evidence of clinical effectiveness and safety [5].

The peptide had been in category 2, for bulk substances that may present significant safety risks, and moved to the 'nominated but withdrawn' table after the nominators withdrew. FDA's page dated 04/22/2026 still posts its concerns: a significant risk of immunogenicity for certain routes of administration, peptide-impurity and characterization problems, and safety information it called inadequate to understand the extent of any safety issues [6].

Outsourcing facilities work from a separate list. On FDA's list for outsourcing facilities, updated March 21, 2025, thymosin alpha-1 is category 3, 'nominated without adequate support' [4]. HHS's October 2026 draft enforcement-discretion policy names six peptides — BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 — and thymosin alpha-1 is not among them [2].

Questions worth asking

Choose the questions you want to keep

Is it banned in sport?

WADA does not name thymosin alpha-1 on its 2026 Prohibited List [7]. WADA does name thymosin-beta-4 and its derivatives such as TB-500 in section S2.3 (growth factors), a different peptide. The S0 category covers substances with no approval from any governmental health authority, and thymosin alpha-1 is approved in some countries [7][1].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. How many US orphan drug designations does thymosin alpha-1 have?

Question 1 of 4

Score: 0 right, 0 of 4 answered

Is thymosin alpha-1 legal in Michigan?
It has no FDA approval, and no FDA or HHS action allowing its compounding was found [1][2]. No Michigan-specific permission or ban was identified, so the federal status applies. It appears in none of FDA's three categories for state-licensed pharmacies and in category 3, 'nominated without adequate support', for outsourcing facilities [3][4].
Is thymosin alpha-1 FDA-approved?
No. There is no US marketing application for it, and its four US orphan drug designations are a separate process from approval [1]. It is approved as a medicine in some countries, including Italy, India and Hong Kong, and the European Medicines Agency holds only an orphan designation for hepatocellular carcinoma [1].
Can a state-licensed compounding pharmacy make thymosin alpha-1?
FDA's list for state-licensed pharmacies has three categories and thymosin alpha-1 is in none of them, so the category 1 policy that generally shields compounders does not apply [3]. FDA proposed that it not be added to the bulks list, and the advisory committee voted 4 yes and 17 no on both the free base and the acetate [5].
Does WADA ban thymosin alpha-1?
Not by name. It is not named on WADA's 2026 Prohibited List [7]. The peptide named in section S2.3 is thymosin-beta-4 and its derivatives such as TB-500, which are different [7].
Show all 10 referencesHide references
Evidence overview for Is Thymosin Alpha-1 Legal in Michigan?